YMAB icon

Y-mAbs Therapeutics

97 hedge funds and large institutions have $394M invested in Y-mAbs Therapeutics in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
Holders Change %
0%
% of All Funds
1.5%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
38
Reduced
28
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$69.2M -$109K -6,715 -0.2%
BlackRock
2
BlackRock
New York
$44.9M +$494K +30,500 +1%
SI
3
Sofinnova Investments
California
$35.6M
AllianceBernstein
4
AllianceBernstein
Tennessee
$31.5M +$8.5M +524,525 +37%
Vanguard Group
5
Vanguard Group
Pennsylvania
$29.5M +$213K +13,150 +0.7%
Artisan Partners
6
Artisan Partners
Wisconsin
$25.6M -$1.73M -106,711 -6%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$24.7M
State Street
8
State Street
Massachusetts
$23.6M +$2.02M +124,727 +9%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$10.1M +$711K +43,866 +8%
MB
10
MPM BioImpact
Massachusetts
$7.24M -$106K -6,513 -1%
AG
11
Artal Group
Luxembourg
$6.48M
LOAMS
12
Lombard Odier Asset Management (Switzerland)
Switzerland
$6.25M +$528K +32,601 +9%
Northern Trust
13
Northern Trust
Illinois
$5.58M -$49.4K -3,047 -0.9%
SCM
14
Soleus Capital Management
Connecticut
$5.03M +$726K +44,794 +17%
CAM
15
Cormorant Asset Management
Massachusetts
$4.86M -$3.24M -200,000 -40%
Morgan Stanley
16
Morgan Stanley
New York
$4.71M +$3.34M +206,378 +246%
LGM
17
Logos Global Management
California
$4.05M +$4.05M +250,000 New
Charles Schwab
18
Charles Schwab
California
$3.97M +$83.1K +5,125 +2%
New York State Common Retirement Fund
19
New York State Common Retirement Fund
New York
$3.83M -$1.07M -65,714 -22%
ACM
20
Ashford Capital Management
Delaware
$3.67M -$3.66M -225,930 -50%
Goldman Sachs
21
Goldman Sachs
New York
$3.52M -$9.66M -595,994 -73%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$3.11M +$1.07M +66,280 +53%
MSKCC
23
Memorial Sloan Kettering Cancer Center
New York
$3.1M -$417K -25,740 -12%
CS
24
Candriam SCA
Luxembourg
$2.98M +$89.3K +5,511 +3%
Citadel Advisors
25
Citadel Advisors
Florida
$2.04M +$343K +21,183 +20%